Jess and Mitch discuss the Neuralink's Blindsight device, a brain implant aimed at restoring vision in blind individuals, has received Breakthrough Device Designation from the FDA. This designation accelerates the device's development and review process, recognizing its potential to provide a significant improvement in vision for those who have lost it, including those born blind. The implant uses electrodes to stimulate the visual cortex, allowing the brain to perceive visual information from an external camera. While initial vision will be low resolution, the device has the potential to exceed natural vision and even enable seeing in infrared and ultraviolet wavelengths. The Blindsight device represents a major step in restoring sight for individuals with severe blindness, offering a glimpse into a future where brain-computer interfaces could revolutionize medical treatments.

Disclaimer:
** The hosts of this podcast are not medical professionals. The content shared in this episode is for informational purposes only and should not be considered medical advice. If you are considering any medical action or decision, please consult with a licensed healthcare provider or medical expert for proper guidance and recommendations.
** The podcast audio is generated by Google AI.
** Image of Jess and Mitch by wayhomestudio on Freepik.

Ver todos los episodios